A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and ongoing trials assessing their efficacy and safety. Thus, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosaeed, Mohammad, Mahmoud, Ebrahim, Hussein, Mohammad, Alharbi, Ahmad, Alsaedy, Abdulrahman, Alothman, Adel, Aljeraisy, Majed, Alqahtani, Hajar, Nashabat, Marwan, Almutairi, Badriah, Almaghaslah, Manar, Aldibasi, Omar, AlJohani, Sameera, Bouchama, Abderrezak, Arabi, Yaseen, Alaskar, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602769/
https://www.ncbi.nlm.nih.gov/pubmed/33129363
http://dx.doi.org/10.1186/s13063-020-04825-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602769/
https://www.ncbi.nlm.nih.gov/pubmed/33129363
http://dx.doi.org/10.1186/s13063-020-04825-x

Ejemplares similares